Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Strati

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 27, 2024
Bispecific Antibody Use in Patients With Lymphoma and Multiple MyelomaAdam Braun, Sushanth Gouni, Astrid Pulles, et al.
Leukemia & Lymphoma|July 2, 2013
Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemiaPaolo Strati, Alessandra Ferrajoli, Susan Lerner, et al.
Cancers|June 22, 2023
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and BeyondSalvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2015
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemiaPaolo Strati, Lynne V Abruzzo, William G Wierda, et al.
The American Journal of Surgical Pathology|August 10, 2020
Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma: A Report of 11 Cases Correlating Clinicopathologic and Radiologic FindingsHong Fang, Hubert H Chuang, Paolo Strati, et al.
Annals of Hematology|May 17, 2019
Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosisPaolo Strati, Maen Abdelrahim, Umut Selamet, et al.
Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.
Multiple Sclerosis and Related Disorders|January 28, 2021
Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosisJoseph A Chacko, Paolo Strati, Paul W Stout, et al.
Leukemia & Lymphoma|December 31, 2021
Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphomaSushanth Gouni, Paolo Strati, Gokce Toruner, et al.
Leukemia Research|November 5, 2017
JAK2<sup>V617F</sup> detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosisPaolo Strati, Christopher B Benton, Taghi Manshouri, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|June 27, 2024
Bispecific Antibody Use in Patients With Lymphoma and Multiple MyelomaAdam Braun, Sushanth Gouni, Astrid Pulles, et al.
Leukemia & Lymphoma|July 2, 2013
Fludarabine, cyclophosphamide and rituximab plus granulocyte macrophage colony-stimulating factor as frontline treatment for patients with chronic lymphocytic leukemiaPaolo Strati, Alessandra Ferrajoli, Susan Lerner, et al.
Cancers|June 22, 2023
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and BeyondSalvatore Perrone, Paolo Lopedote, Vitaliana De Sanctis, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 25, 2015
Second cancers and Richter transformation are the leading causes of death in patients with trisomy 12 chronic lymphocytic leukemiaPaolo Strati, Lynne V Abruzzo, William G Wierda, et al.
The American Journal of Surgical Pathology|August 10, 2020
Postchemotherapy Histiocyte-rich Pseudotumor Mimicking Residual Lymphoma: A Report of 11 Cases Correlating Clinicopathologic and Radiologic FindingsHong Fang, Hubert H Chuang, Paolo Strati, et al.
Annals of Hematology|May 17, 2019
Ruxolitinib therapy is associated with improved renal function in patients with primary myelofibrosisPaolo Strati, Maen Abdelrahim, Umut Selamet, et al.
Cancer|August 15, 2013
Myelosuppression after frontline fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: analysis of persistent and new-onset cytopeniaPaolo Strati, William Wierda, Jan Burger, et al.
Multiple Sclerosis and Related Disorders|January 28, 2021
Primary mediastinal large B-cell lymphoma in a patient on Fingolimod for relapsing-remitting multiple sclerosisJoseph A Chacko, Paolo Strati, Paul W Stout, et al.
Leukemia & Lymphoma|December 31, 2021
Statins enhance the chemosensitivity of R-CHOP in diffuse large B-cell lymphomaSushanth Gouni, Paolo Strati, Gokce Toruner, et al.
Leukemia Research|November 5, 2017
JAK2<sup>V617F</sup> detection and allele burden measurement in saliva vs. peripheral blood in patients with myelofibrosisPaolo Strati, Christopher B Benton, Taghi Manshouri, et al.
Pageof 14